81
Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients
Condition(s):Breast Cancer; Neoplasm MetastasisLast Updated:February 21, 2019Completed
Vinorelbine: 523 Clinical Trials, Page 9 of 53
Hide Studies Not Open or Pending
82
A Study of Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician’s Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:June 25, 2019Unknown status
83
Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:July 21, 2014Terminated
84
Oral Vinorelbine or Capecitabine Combined With Trastuzumab as Adjuvant Treatment for Patients With Lymph Node Negative, HER-2 Positive and Small Tumor Size Breast Cancer (ORCHID)
Condition(s):Breast CancerLast Updated:March 5, 2020Unknown status
85
Phase II Study of Gemcitabine/Vinorelbine vs Sequential Gemcitabine Followed by Vinorelbine in Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:June 27, 2011Completed
86
Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer
Condition(s):Breast Cancer; Advanced Malignant Solid TumorsLast Updated:August 9, 2018Completed
87
Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer
Condition(s):Non-small Cell Lung CancerLast Updated:July 22, 2009Completed
88
Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC)
Condition(s):Non-small Cell Lung CancerLast Updated:December 10, 2010Unknown status
89
Study to Compare Vinorelbine In Combination With the mTOR Inhibitor Everolimus vs. Vinorelbin Monotherapy for Second-line Treatment in Advanced Breast Cancer
Condition(s):Her2-negative Metastatic Breast Cancer; Her2-negative Locally Advanced Breast CancerLast Updated:August 9, 2017Completed
90
Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer – MA.NI.LA Trial
Condition(s):Non-small Cell Lung Cancer Stage IIIB; Non-small Cell Lung Cancer Stage IVLast Updated:April 22, 2019Completed